Firm and non-firm actor collaborations as a determinant of countries' readiness, progress and success for developing COVID-19 vaccines
by Jahan Ara Peerally; Claudia De Fuentes; Fernando Santiago; Julia Paranhos
International Journal of Technology Management (IJTM), Vol. 94, No. 3/4, 2024

Abstract: Using the national technological capability (NTC) approach, we examine the influence of different configurations of firm and non-firm actors' collaborations on countries' level of readiness, progress and success for developing a COVID-19 vaccine. We create a country index which captures the spectrum from readiness, progress to success. The effects of NTC macro-level determinants and the micro-level collaborations on the index are informative. Higher levels of progress and success by countries are determined by: 1) NTCs which focus on sound supporting healthcare institutions; 2) advanced NTCs and advanced biopharmaceutical sector capabilities which also lead to better global collaborations by firm and non-firm actors; 3) non-firm sector collaborations. For lower readiness and progress countries: 1) the bulk of knowledge for developing a vaccine resides in interfirm collaborations; 2) non-firm collaborations negatively impact their readiness, progress, and success. We discuss the implications of these results for policy, practice, and future research.

Online publication date: Thu, 01-Feb-2024

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Management (IJTM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com